Skip to content
OpenCapital
Get started

Globe Life GL Cash, Cash Equivalents, and Marketable Securities

Cash, Cash Equivalents, and Marketable Securities at other companies

Corebridge Financial logo
Corebridge FinancialCRBG
——
Fidelity National Financial logo
Fidelity National FinancialFNF
——
Assurant logo
AssurantAIZ
——
Cincinnati Financial logo
Cincinnati FinancialCINF
——
Humana logo
HumanaHUM
——
Arch Capital Group logo
Arch Capital GroupACGL
——

Other financials

Income statement

See full
Revenue$1.6B+5.3%
Net income$270.5M+6.3%
EPS (diluted)$3.39+12.6%

Balance sheet

See full
Cash & equivalents$255.2M+9.9%
Total debt$3.2B-1.3%
Total equity$6.1B+12.1%
Total assets$31.0B+4.2%

Cash flow

See full
Operating cash flow$420.9M-2.5%
CapEx$24.9M+112%
Free cash flow$396.0M-5.7%

Valuation

See full
Market cap$13.26B-0.4%
Enterprise value$16.24B-0.8%
P/E11.3×-1.2×
P/S2.2×-0.1×

Profitability

See full
Net margin19.4%+1.0pp
FCF margin20.2%-3.9pp

Returns & leverage

See full
Return on equity20.5%0.0pp
Debt / equity0.5×-0.1×

Where this comes from

Reported directly by Globe Life in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition.

The official record: Globe Life’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globe Life's cash, cash equivalents, and marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globe Life's cash, cash equivalents, and marketable securities?
Globe Life (GL) reported cash, cash equivalents, and marketable securities of $11.3B in Q1 2026.
How has Globe Life's cash, cash equivalents, and marketable securities changed year-over-year?
Globe Life's cash, cash equivalents, and marketable securities increased by 0.9% year-over-year, from $11.2B to $11.3B.
What is the long-term trend for Globe Life's cash, cash equivalents, and marketable securities?
Over 5 years (2020 to 2025), Globe Life's cash, cash equivalents, and marketable securities has grown at a 84.2% compound annual growth rate (CAGR), from $495.23M to $10.5B.